Matriderm® Usa (exclusively Distributed By Apm)

What Matriderm® Usa (exclusively Distributed By Apm) does

Access Pro Medical, Inc. (APM) is a privately held medical device distribution company headquartered in Augusta, Georgia, that holds exclusive U.S. distribution rights for MatriDerm, a single-use acellular dermal matrix manufactured by MedSkin Solutions by Dr. Suwelack. MatriDerm is composed of native bovine collagen types I, III, and V with added elastin derived from bovine nuchal ligament, formulated without chemical cross-linking or non-permeable layers, and is offered in two thicknesses (1MM and 2MM) across four sheet sizes to accommodate shallow versus complex wound applications. The product vascularizes in 3-7 days and reports infection rates of 0-5% in published literature, compared with 21-28 day vascularization and 14-55% infection rates cited for the market-leading competitor.

The company's go-to-market is a sales-led enterprise motion targeting U.S. hospitals and healthcare systems, with field sales representatives and Strategic Market Development Managers engaging surgeons, hospital administrators, procurement teams, and value-analysis committees. Revenue is generated through quote-based hardware sales under multi-year hospital contracts, with 1,441+ U.S. hospitals currently contracted. The company complements the MatriDerm line with the Maxxeus Burn skin allograft distributed through an exclusive partnership with Solvita (formerly Community Tissue Services). APM is in the early phase of a U.S. scale-up following MatriDerm's 2024 domestic launch after more than 20 years of international clinical use and over 200 supporting publications, including 5 RCTs and a 12-year follow-up study.

Name

Matriderm® Usa (exclusively Distributed By Apm)

Legal name

Access Pro Medical, Inc.

Website

https://www.matridermusa.com

Company type

Private

Operating status

Operating

Short description

Access Pro Medical is the exclusive U.S. distributor of MatriDerm, a single-use acellular collagen-elastin dermal matrix for wound management, burn, and reconstructive surgery, sold through enterprise sales contracts to 1,441+ U.S. hospitals.

Ownership category

akta.pro rank

Product category

Wound Care Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

Keywords

• Dermal matrix products
• Wound management devices
• Soft tissue reconstruction
• Burn care medical devices
• Acellular dermal matrix

Headquarters

HQ city

Augusta

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Medical Device Sales - Dermal Matrix: Revenue generated from the sale of MatriDerm dermal matrix products to U.S. hospitals and healthcare facilities. The company sells directly to healthcare providers through enterprise sales contracts with 1441+ U.S. hospitals currently on contract.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

MatriDerm is a single-use acellular dermal matrix composed of native bovine collagen I, III, and V with added elastin, used for wound management, burn surgery, plastic reconstruction, traumatic injury, chronic wounds, cancer excision, flap donor sites, and mucosal defects. It is sold in 1MM and 2MM thicknesses across four sheet sizes to U.S. hospitals and healthcare facilities, exclusively distributed in the U.S. by Access Pro Medical, Inc.

Product overview

MatriDerm® is a single-product medical device company offering a single-use acellular dermal matrix for wound management, burn surgery, and soft tissue reconstruction. The core product MatriDerm is composed of native bovine collagen I, III, and V with added elastin. It is available in two thicknesses (1MM for shallow wounds and 2MM for deeper wounds), each offered in four sheet sizes. The product is distributed exclusively in the U.S. by Access Pro Medical based in Augusta, GA. A complementary product, Maxxeus Burn Skin Allograft (from Solvita/Community Tissue Services), is also distributed by Access Pro Medical. With 20+ years of clinical evidence including over 200 publications and 5 RCTs, MatriDerm is positioned as a disruptive technology in soft tissue reconstruction.

Differentiator

Problem solved

Functional benefit

Products and services

• MatriDerm Single-use acellular dermal matrix composed of native bovine collagen I, III, and V with added elastin, used for wound management, burn surgery, reconstructive surgery, plastic reconstruction, traumatic injury, chronic wounds, cancer excision, flap donor sites, and mucosal defects. Vascularizes in 3-7 days with reported infection rates of 0-5%. Sold to U.S. hospitals and healthcare facilities.
• MatriDerm 1MM 1MM thickness variant of MatriDerm designed for shallow wounds and/or faster vascularization, available in four sheet sizes. Sold to U.S. hospitals and surgical teams for wound management and soft tissue reconstruction.
• MatriDerm 2MM 2MM thickness variant of MatriDerm designed for more complex or deeper wounds, available in four sheet sizes. Sold to U.S. hospitals and surgical teams for wound management and soft tissue reconstruction.
• Maxxeus Burn Skin Allograft Burn skin allograft product available through exclusive partnership with Solvita (formerly Community Tissue Services), distributed by Access Pro Medical alongside MatriDerm for burn and wound care applications at U.S. healthcare facilities.

Quantifiable outcome

• Vascularization time: 3-7 days (vs 21-28 days for leading competitor)
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• MedSkin Solutions by Dr. SuwelackcoreOEM/ Whitelabel/ Licensing PartnerExclusive agreement providing Access Pro Medical rights to distribute MatriDerm in the United States. MedSkin Solutions manufactures the MatriDerm product using proprietary collagen-elastin matrix technology developed with over 20 years of clinical use globally.
• Solvita (formerly Community Tissue Services)coreOEM/ Whitelabel/ Licensing PartnerExclusive partnership for the unique line of Maxxeus Burn allograft products. Solvita provides burn skin allograft products that complement MatriDerm and Access Pro Medical's soft tissue reconstruction portfolio.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@accesspromedical6103
• Facebookfacebook.com/AccessProMedical
• LinkedInlinkedin.com/company/access-pro-medical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Matriderm® Usa (exclusively Distributed By Apm)